SMCHD1 and arhinia, choanal atresia, and microphthalmia: Even though the equivalent A667E variant has never been observed in BAMS patients, the effects of MommeD43 on SMCHD1 on transgene silencing, Hox gene expression, and skeletal patterning are consistent with a gain-of-function.